<?xml version="1.0" encoding="UTF-8"?><oembed><type>video</type><version>1.0</version><html>&lt;iframe src=&quot;https://www.loom.com/embed/f909583777594edba5630e5b32f5db78&quot; frameborder=&quot;0&quot; width=&quot;1900&quot; height=&quot;1425&quot; webkitallowfullscreen mozallowfullscreen allowfullscreen&gt;&lt;/iframe&gt;</html><height>1425</height><width>1900</width><provider_name>Loom</provider_name><provider_url>https://www.loom.com</provider_url><thumbnail_height>1425</thumbnail_height><thumbnail_width>1900</thumbnail_width><thumbnail_url>https://cdn.loom.com/sessions/thumbnails/f909583777594edba5630e5b32f5db78-ba143ff84ba5383d.gif</thumbnail_url><duration>183.744</duration><title>Age and Interstitium for ED Follow-Up</title><description>This Loom discusses an interstitial ED follow-up approach for the in-between patient after ER discharge. It explains that current ER software assumes patients will return, so clinicians must manually review discharged patients daily, which wastes resources and increases repeated ER use and administrative burden. Using a urinary tract infection example, it describes verifying patient contact, assigning who follows up on urine culture results, and then handling antibiogram-driven changes when the patient is resistant to ciprofloxacin. The agent then calls the patient, checks red flag symptoms and drug allergies, and ideally transmits the updated order to the pharmacy to prevent complications like sepsis.</description></oembed>